Elevated Protein S Provides Evidence against Hypoxia-Induced Hypercoagulation in Tibetan Highlanders with PHD2D4E;C127S Polymorphisms

Nishith M. Shrimali; Riya Ghosh; Kanchan Bhardwaj; Chorol Tsewang; Tashi Thinlas; Parvaiz Koul; Josef T. Prchal; Prasenjit Guchhait

doi:10.1055/a-2580-0107

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost
DOI: 10.1055/a-2580-0107

Letter to the Editor

Elevated Protein S Provides Evidence against Hypoxia-Induced Hypercoagulation in Tibetan Highlanders with PHD2^D4E;C127S Polymorphisms

Authors

Nishith M. Shrimali^*

¹Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, Haryana, India
Riya Ghosh^*

¹Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, Haryana, India

²Manav Rachna International Institute of Research and Studies, Faridabad, Haryana, India
Kanchan Bhardwaj

¹Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, Haryana, India

²Manav Rachna International Institute of Research and Studies, Faridabad, Haryana, India
Chorol Tsewang

³Department of Surgery, Sonam Nurboo Memorial Hospital, Leh-Ladakh, Jammu and Kashmir, India
Tashi Thinlas

⁴Department of Medicine, Sonam Nurboo Memorial Hospital, Leh-Ladakh, Jammu and Kashmir, India
Parvaiz Koul

⁵Department of Internal and Pulmonary Medicine, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India
Josef T. Prchal

⁶Department of Medicine, University of Utah School of Medicine and Huntsman Cancer Center and George E. Whalen Veteran's Administration Medical Center, Salt Lake City, Utah, United States
Prasenjit Guchhait

¹Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, Haryana, India

Abstract

Full Text

References

References
1 Cobb AB, Levett DZH, Mitchell K. et al; Caudwell Xtreme Everest, Xtreme Everest 2009, Xtreme Everest 2 investigators. Physiological responses during ascent to high altitude and the incidence of acute mountain sickness. Physiol Rep 2021; 9 (07) e14809
2 Luks AM, Swenson ER. Travel to high altitude with pre-existing lung disease. Eur Respir J 2007; 29 (04) 770-792
3 Stavik B, Espada S, Cui XY. et al. EPAS1/HIF-2 alpha-mediated downregulation of tissue factor pathway inhibitor leads to a pro-thrombotic potential in endothelial cells. Biochim Biophys Acta 2016; 1862 (04) 670-678
4 Chaurasia SN, Kushwaha G, Kulkarni PP. et al. Platelet HIF-2α promotes thrombogenicity through PAI-1 synthesis and extracellular vesicle release. Haematologica 2019; 104 (12) 2482-2492
5 Pilli VS, Datta A, Afreen S, Catalano D, Szabo G, Majumder R. Hypoxia downregulates protein S expression. Blood 2018; 132 (04) 452-455
6 Simonson TS, Yang Y, Huff CD. et al. Genetic evidence for high-altitude adaptation in Tibet. Science 2010; 329 (5987) 72-75
7 Bigham A, Bauchet M, Pinto D. et al. Identifying signatures of natural selection in Tibetan and Andean populations using dense genome scan data. PLoS Genet 2010; 6 (09) e1001116
8 Lorenzo FR, Huff C, Myllymäki M. et al. A genetic mechanism for Tibetan high-altitude adaptation. Nat Genet 2014; 46 (09) 951-956
9 Beall CM, Cavalleri GL, Deng L. et al. Natural selection on EPAS1 (HIF2α) associated with low hemoglobin concentration in Tibetan highlanders. Proc Natl Acad Sci U S A 2010; 107 (25) 11459-11464
10 Bhattacharya S, Shrimali NM, Mohammad G, Koul PA, Prchal JT, Guchhait P. Gain-of-function Tibetan PHD2^D4E;C127S variant suppresses monocyte function: A lesson in inflammatory response to inspired hypoxia. EBioMedicine 2021; 68: 103418
11 Shrimali NM, Agarwal S, Kaur S. et al. α-Ketoglutarate inhibits thrombosis and inflammation by prolyl hydroxylase-2 mediated inactivation of phospho-Akt. EBioMedicine 2021; 73: 103672
12 Chattopadhyay R, Sengupta T, Majumder R. Inhibition of intrinsic Xase by protein S: a novel regulatory role of protein S independent of activated protein C. Arterioscler Thromb Vasc Biol 2012; 32 (10) 2387-2393
13 Kaur S, Singh A, Kaur J. et al. Upregulation of cytokine signalling in platelets increases risk of thrombophilia in severe COVID-19 patients. Blood Cells Mol Dis 2022; 94: 102653
14 Dahlbäck B. Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system. Thromb Haemost 1991; 66 (01) 49-61
15 Wilson HP, Pierre A, Paysse AL. et al. Protein S antibody as an adjunct therapy for hemophilia B. Blood Adv 2024; 8 (02) 441-452
16 Gupta N, Sahu A, Prabhakar A. et al. Activation of NLRP3 inflammasome complex potentiates venous thrombosis in response to hypoxia. Proc Natl Acad Sci U S A 2017; 114 (18) 4763-4768
17 Calzavarini S, Prince-Eladnani R, Saller F. et al. Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombus. Blood 2020; 135 (22) 1969-1982
18 Prabhakar A, Chatterjee T, Bajaj N. et al. Venous thrombosis at altitude presents with distinct biochemical profiles: a comparative study from the Himalayas to the plains. Blood Adv 2019; 3 (22) 3713-3723